Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.3500
+0.0039 (1.13%)
At close: Sep 26, 2025, 4:00 PM EDT
0.3449
-0.0051 (-1.46%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $14.50 million as of September 26, 2025. Its market cap has decreased by -86.32% in one year.
Market Cap
14.50M
Enterprise Value
-3.59M
1-Year Change
-86.32%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $14.50M, a decrease of -80.35%. That is a compound annual growth rate of -17.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 14.50M | -86.84% |
| Dec 31, 2024 | 110.20M | 3.96% |
| Dec 29, 2023 | 106.00M | 137.67% |
| Dec 30, 2022 | 44.60M | -84.42% |
| Dec 31, 2021 | 286.20M | 113.26% |
| Dec 31, 2020 | 134.20M | 395.20% |
| Dec 31, 2019 | 27.10M | -7.82% |
| Dec 31, 2018 | 29.40M | -49.83% |
| Dec 29, 2017 | 58.60M | -20.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |